Efficacy, safety and biological profile of a new 2-litre gut cleansing solution with PEG3350 plus electrolytes in risk groups undergoing colonoscopy
C Ell, W Fischbach, HJ Bronisch, S Dertinger, P Layer, M Ruenzi, T Schneider, G Kachel, J Grueger, V Gross, W Nagell, G Preclik, HJ Gruss · Zeitschrift für Gastroenterologie · 2006 · Heft 04
Bibliografische Angaben
Zusammenfassung
Aim: To demonstrate that a new oral 2L gut cleansing solution PEG+E plus ascorbate (2L PEG+E) is as safe and well tolerated as the standard 4L PEG+E bowel preparation in risk group patients undergoing colonoscopy. Methods: A randomised, single-blind, multicentre study comparing 2L PEG+E (Sol.A) with 4L standard PEG+E (Sol.B) in patients (aged: 18–85 years) undergoing colonoscopy. Several subgroups were included: elderly, patients with inflammatory bowel disease (IBD), concomitant cardiovascular (CV) disease or impaired kidney function (creatinine clearance